Home > Healthcare > Medical Devices > Medical Supplies > Antimicrobial Hospital Textile Market

Antimicrobial Hospital Textile Market Share

Report ID: GMI10939
Published Date: Aug 2024
Report Format: PDF

Download Free Sample

Antimicrobial Hospital Textile Market Share

The antimicrobial hospital textile sector is competitive and fragmented, encompassing a blend of major global players as well as smaller and medium-sized companies. Success in this market depends on the continuous introduction of innovative textiles that incorporate advanced technologies, such as enhanced antimicrobial coatings and performance features. Leading companies shape market trends through substantial investments in research and development, as well as strategic activities including partnership, collaboration, acquisitions, and mergers. Smaller firms often target niche segments or specialized applications to effectively compete with established players. These dynamics contribute to rapid market evolution and growth.

Antimicrobial Hospital Textile Market Companies

Some of the eminent market participants operating in the antimicrobial hospital textile industry include:

Balavigna Mills Pvt. Ltd.
Cotton Inc.
Grasim Industries Limited
Herculite
Indorama Ventures Lifestyle Italy S.p.A.
Milliken & Company
MOLLYFLEX Srl
Piranha Brands LLC. (LifeThreads)
Smartfiber AG
Stafford Textiles Limited
Surgicotfab Textiles Pvt. Ltd.
Swicofil AG
Toyobo Co., Ltd.
Unico I.T.C.
W.Ball & Son Limited

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global antimicrobial hospital textile industry was valued at USD 8.3 billion in 2023 and is anticipated to register 6.7% CAGR between 2024 and 2032, driven by the rising prevalence of healthcare-associated infections.

The reusable segment in the market accounted for USD 5.2 billion in 2023 due to its durability and antimicrobial treatments, decreasing waste and ensuring ongoing protection in healthcare.

U.S. antimicrobial hospital textile market is expected to reach USD 4.9 billion by 2032, fueled by the increasing investments in R&D of new antimicrobial technologies.

Balavigna Mills Pvt. Ltd., Cotton Inc., Grasim Industries Limited, Herculite, Indorama Ventures Lifestyle Italy S.p.A., Milliken & Company, MOLLYFLEX Srl, Piranha Brands LLC. (LifeThreads), and Smartfiber AG, among others.